Gamma Knife Market: Size, Dynamics, Regional Insights and Market Segment Analysis

Gamma Knife Market Overview

Gamma Knife radiosurgery is a type of radiotherapy treatment. It is also called stereotactic radiosurgery.  It can be used to treat tumors, veins that have developed differently than usual, and other differences in the brain.

 

The global Gamma Knife market is experiencing significant growth driven by the rising incidence of neurological disorders and ongoing technological advancements. Gamma Knife radiosurgery has emerged as a preferred treatment for conditions such as brain tumors, arteriovenous malformations (AVMs), and functional disorders due to its precise and non-invasive nature. Technological advancements present significant opportunities for the Gamma Knife market's growth and expansion. Modern Gamma Knife systems now feature enhanced imaging and targeting capabilities, including high-resolution MRI and CT scans, which improve tumor localization and treatment precision. These advancements improve treatment efficacy and patient comfort, making Gamma Knife radiosurgery a more attractive option and driving demand in the global market.

 

The market is segmented based on indications, anatomy, end-use, and region. The malignant tumor segment holds a dominant position due to the high prevalence of brain tumors and the need for precise treatments. Regionally, Asia-Pacific helds the largest market share, with China and India emerging as significant contributors. China’s advancements in domestic Gamma Knife systems and India’s status as a major medical tourism destination bolster the market's growth. The competitive landscape features key players such as Elekta AB, Varian Medical Systems, and emerging regional players like Shenzhen Haibo S&T Co., Ltd., each vying for market share through technological innovation and strategic initiatives.

 

To get more Insights: Request Free Sample Report

 

Global Gamma Knife Market Dynamics

Global Gamma Knife Market Drivers

Increasing Incidences of Neurological Disorders

The rising incidence of neurological disorders significantly drives the global Gamma Knife market by increasing the demand for precise and non-invasive treatment options. Neurological conditions such as brain tumors, arteriovenous malformations (AVMs), and functional disorders like trigeminal neuralgia are becoming more prevalent due to an aging population and advances in diagnostic imaging that improve detection rates. Gamma Knife radiosurgery has become a preferred treatment for conditions like brain metastases and AVMs due to its ability to deliver high doses of radiation precisely to the affected areas, leading to improved patient outcomes. As the incidence of these disorders increases, the demand for Gamma Knife systems is expected to increase, further driving the market and leading to continued innovation in treatment technology.

 

According to Analysis, 1 million Americans are currently living with a brain tumor, and 94,390 new cases are diagnosed in 2023. Despite advancements in treatment, the relative survival rate for patients with malignant brain tumors stands at 35.7%. Tragically, 18,990 Americans are anticipated to die from malignant brain tumors this year. As these conditions rise, there is a growing need for effective, non-invasive treatment options like Gamma Knife radiosurgery, which offers precise tumor targeting with minimal damage to surrounding healthy tissue.

Global Gamma Knife Market opportunities

Technological advances represent a major opportunity for the growth and expansion of the global Gamma Knife market by driving innovation, improving treatment outcomes, and improving the overall patient experience. In modern Gamma Knife systems, imaging and targeting capabilities have improved significantly. Advanced imaging techniques, such as high-resolution MRI and CT scans integrated into Gamma Knife systems, allow more precise localization of tumors and lesions. This precision improves treatment efficacy, reduces the risk of damage to healthy tissue, and improves patient outcomes.

 

Advances in technology make Gamma Knife systems even more user-friendly and versatile. Advanced robotics and automation capabilities streamline the treatment process, reducing set-up time and increasing performance. These improvements also improve patient comfort and reduce procedural stress. Innovations such as real-time monitoring and adaptive radiation delivery systems continue to support market growth by providing healthcare professionals with the tools to tailor treatment to individual patient needs and adapt to changes during the procedure. As technology advances, these advances are likely to make Gamma Knife radiosurgery an even more attractive option for the treatment of neurological disorders, increasing demand and expanding market opportunities worldwide.

 

Global Gamma Knife Market Challenges

Gamma Knife radiosurgery presents some challenges in the global market due to possible side effects. Immediate side effects such as scalp swelling, headache, skin irritation, nausea and rare seizures can affect patient comfort and satisfaction, while late effects such as hair loss, localized brain swelling and facial numbness cause long-term problems. These side effects, although generally mild compared to traditional surgery, can still affect patient outcomes and treatment decisions. Addressing these challenges through improved patient education, advanced technology, and tailored care strategies is crucial for enhancing the overall efficacy and acceptance of Gamma Knife radiosurgery worldwide.

 

The high costs associated with Gamma Knife systems and their maintenance present another significant challenge in the global gamma knife market. The initial investment required for purchasing Gamma Knife systems is substantial, often exceeding several million dollars, which can be prohibitive for hospitals and clinics in these regions. Additionally, ongoing maintenance, including technical support, calibration, and software updates, incurs further expenses that can strain healthcare budgets.

 

Global Gamma Knife Market Segmentation

Based On Indications, the Global Gamma Knife Market is segmented into Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorder and Ocular Diseases. Malignant Tumor Segment dominated the Global Gamma Knife Market in 2023 due to the increasing prevalence of brain tumors and the need for precise, non-invasive treatments. Approximately Xx% of all brain tumors are malignant. The growth of this segment is fueled by the high prevalence and complexity of treating these tumors. Additionally, the prevalence of malignant tumors has driven ongoing advancements and investments in Gamma Knife technology, which strengthened its dominant position in the market.

 

According to Stellar’s Analysis

• Malignant primary brain tumors occur more often in males (55.8%) than in females (44.2%)
• Males have higher mortality rates from malignant brain tumors than females.

Based On Anatomy, the Global Gamma Knife Market is segmented into Head, Neck, and Others. In 2023, the Head segment held the largest share accounting for Xx% of the overall market share. This is due to the high prevalence of neurological disorders such as brain tumors, arteriovenous malformations (AVMs), and functional disorders affecting the head and brain. The Gamma Knife is particularly effective for treating lesions within the brain due to its precision in delivering high-dose radiation to targeted areas while minimizing exposure to surrounding healthy tissue. Advancements in imaging and treatment planning specific to head lesions enhance the accuracy and outcomes of Gamma Knife procedures, strengthening its leading position in the market.

 

• According to the World Health Organization (WHO), approximately 300,000 new brain and central nervous system Tumor cases are diagnosed yearly.

Based On End-Use, the Global Gamma Knife Market is segmented into Hospitals, Clinics, and Ambulatory Surgery Centers. The Hospital segment dominated the global gamma knife market and held the largest market share of Xx% in 2023. Hospitals are the primary settings for advanced cancer treatments.  Hospitals usually have multidisciplinary teams with various healthcare professionals, including oncologists, radiologists, pathologists, and nurses. Hospitals often have the resources to invest in advance technology and provide the necessary support for high-precision procedures.

 

Global Gamma Knife Market Regional Insight

Asia-pacific dominated the Global Gamma Knife market with the largest market share of Xx% in 2023, the region is expected to grow during forecasted period and maintain its dominant position until 2030. This is due to its rapidly expanding healthcare infrastructure, increasing prevalence of neurological disorders and increasing efforts of various government agencies. The leading companies in the APAC Gamma Knife Market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Shenzhen Haibo S&T Co., Ltd, Shenzhen Jiancheng Investment Co., Ltd. And others.

 

China stands out as a major player in the Asia-Pacific Gamma Knife market. The country has significantly expanded its healthcare facilities and advanced medical technologies, including Gamma Knife systems. Shenzhen Haibo S&T Co. Ltd. and Shenzhen Jiancheng Investment Co. Ltd. introduced a new super Gamma Knife system to treat both brain and body tumors. Over time, more than 80 domestic hospitals adopted these locally developed systems, which now hold a significant market share compared to imports. Chinese engineers are now working on next-generation Gamma Knives to further reduce costs and enhance treatment capabilities.

 

India is world’s most affordable destination for worldclass healthcare. Indian hospitals are well-known across the globe for their clinical expertise and efficient operations. The Indian government's efforts to promote advanced medical technology and improve healthcare infrastructure are significantly contributing to growth of gamma knife market.

 

Japanese health facilities, including prominent institutions such as the National Cancer Center and several university hospitals, have integrated advanced Gamma Knife systems to provide precise and effective treatment of neurological diseases. Japan's supremacy in the gamma knife business is bolstered by its strong focus on research and development as well as a well-established infrastructure for cancer care.

 

Global Gamma Knife Market Competitive Landscape

The global Gamma Knife market is highly competitive, driven by key players such as Elekta AB, Varian Medical Systems, Shenzhen Haibo S&T Co., Ltd., Shenzhen Jiancheng Investment Co., Ltd and Accuray Incorporated, aiming to gain market share through technological innovation and strategic positioning. Elekta AB leads the market with its Gamma Knife ICON and Perfexion systems, known for advanced imaging integration and precise dose delivery. Accuray Incorporated designs, develops and sells the CyberKnife Stereotactic Radiosurgery System that also impact the Gamma Knife Market.

 

Competition extends beyond technological advancements, with companies engaging in strategic partnerships, acquisitions, and collaborations to enhance their market presence. In 2021, Siemens Healthineers acquired Varian Medical Systems to address the growing need for personalized, data-driven diagnosis and precision cancer care that enables us to fight back against globally increasing cancer rates. And offers sophisticated Gamma Knife solutions with high precision and integration capabilities.  

 

Elekta Gamma Knife with its ICON and Perfexion systems is at the forefront of advanced technology and comprehensive treatment solutions, with a strong global presence and significant revenue based on its high precision and dose planning. Elekta’s strategy focuses on continuous technological innovation, strategic partnerships, and a strong distribution network. Instead, Shenzhen Haibo is an emerging player in the Asia-Pacific region, offers cost-effective Gamma Knife systems tailored to local needs, contributing to its growing market share. While Haibo’s revenue and portfolio are smaller compared to Elekta’s, its strategy emphasizes affordability and adaptability, making significant inroads in domestic markets. The biggest difference is Elekta's established global reach and technology leadership versus Haibo's focus on regional expansion and competitive pricing.

Global Gamma Knife Market Scope
Market Size in 2023	USD 397 Mn.
Market Size in 2030	USD 582.4 Mn.
CAGR (2024-2030)	5.62%
Historic Data	2018-2022
Base Year	2023
Forecast Period	2024-2030
Segments	By Indications Malignant Tumors Benign Tumors Vascular Disorder Functional Disorder Ocular Diseases
	By Anatomy Head Neck Others
	By End-Use  Hospitals  Clinics  Ambulatory Surgery Centers
Regional Scope	North America United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

 

Global Gamma Knife Market Key Players

1. Elekta AB
2. Varian Medical Systems
3. Shenzhen Haibo S&T Co., Ltd.
4. Shenzhen Jiancheng Investment Co., Ltd
5. Accuray Incorporated
6. Panacea Medical Technologies Pvt. Ltd.
7. Nordion Inc.
8. American Shared Hospital Services
9. UT Health East Texas
10. CyberMed Health Inc.